Literature DB >> 8706499

Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations.

C F Bolton1.   

Abstract

OBJECTIVE: To describe the various conditions of peripheral nerve, neuromuscular junction, and muscle associated with the systemic inflammatory response syndrome (SIRS). DATA SOURCES: Publications in the scientific literature and personal observations during the last 15 yrs. DATA EXTRACTION: Computer search of the literature and review of patient records relating to polyneuropathy, neuromuscular transmission defects, and myopathies associated with sepsis, the septic syndrome, and SIRS. SYNTHESIS: SIRS is a new concept in which infection and trauma induce a systemic inflammatory response affecting the microcirculation to organs throughout the body. The nervous system is commonly affected in the forms of septic encephalopathy and critical illness polyneuropathy. Neuromuscular blocking agents and corticosteroids may have additional toxic effects on the neuromuscular system that are manifest as transient neuromuscular blockade, an axonal motor neuropathy, or a thick filament myopathy. Clinical examination in the critical care unit is often unreliable and electrophysiologic studies, at times accompanied by magnetic resonance imaging of the spinal cord, measurement of the circulating creatine phosphokinase concentration, and muscle biopsy, are often necessary to establish the diagnosis. Variants of critical illness polyneuropathy may occur outside the critical care unit. The precise mechanism of these neuromuscular conditions is not known, and further basic research is needed.
CONCLUSIONS: A variety of neuromuscular conditions complicates SIRS. The identification of these conditions is important in patient management and in rendering a prognosis.

Entities:  

Mesh:

Year:  1996        PMID: 8706499     DOI: 10.1097/00003246-199608000-00022

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  33 in total

1.  Evidence of neuromuscular dysfunction in the early stages of the systemic inflammatory response syndrome.

Authors:  C F Bolton
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

2.  Critical Illness Polyneuropathy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-11       Impact factor: 3.598

Review 3.  Critical illness polyneuropathy and myopathy in the intensive care unit.

Authors:  Wolfgang Zink; Rainer Kollmar; Stefan Schwab
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

4.  An unusual cause of peripheral neuropathy.

Authors:  S Zaman; A Latchford; S Allen
Journal:  Postgrad Med J       Date:  1998-05       Impact factor: 2.401

Review 5.  Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients.

Authors:  Efstratios Apostolakis; Nikolaos A Papakonstantinou; Nikolaos G Baikoussis; George Papadopoulos
Journal:  J Anesth       Date:  2014-07-01       Impact factor: 2.078

6.  Organ dysfunction is associated with hyperglycemia in critically ill children.

Authors:  Ursula G Kyle; Jorge A Coss Bu; Curtis E Kennedy; Larry S Jefferson
Journal:  Intensive Care Med       Date:  2009-10-31       Impact factor: 17.440

7.  Role of endotoxin in the pathogenesis of critical illness polyneuropathy.

Authors:  B Mohammadi; I Schedel; K Graf; A Teiwes; H Hecker; B Haameijer; D Scheinichen; S Piepenbrock; R Dengler; J Bufler
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

8.  Chronic Escherichia coli infection induces muscle wasting without changing acetylcholine receptor numbers.

Authors:  Christiane G Frick; Heidrun Fink; Maria L Gordan; Barbara Eckel; J A Jeevendra Martyn; Manfred Blobner
Journal:  Intensive Care Med       Date:  2007-10-20       Impact factor: 17.440

9.  Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial.

Authors:  Christina Routsi; Vasiliki Gerovasili; Ioannis Vasileiadis; Eleftherios Karatzanos; Theodore Pitsolis; Elli Tripodaki; Vasiliki Markaki; Dimitrios Zervakis; Serafim Nanas
Journal:  Crit Care       Date:  2010-04-28       Impact factor: 9.097

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.